Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | S100A4 | P26447 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30955249 | 1.00 | TSHR (0.60) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL27875768 | 0.98 | TSHR (0.58) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL1459853 | 0.83 | MAPT (0.56) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL31005993 | 0.83 | MAPT (0.56) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL1561802 | 0.80 | TSHR (0.56) | TSHRALDH1A1CYP3A4CYP1A2MAPT | |
| SCHEMBL8147367 | 0.80 | TSHR (0.43) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL8155350 | 0.80 | TSHR (0.43) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL29613904 | 0.78 | TSHR (0.72) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL7190826 | 0.78 | TSHR (0.64) | TSHRALDH1A1CYP3A4RECQLHSD17B10 | |
| SCHEMBL171914 | 0.78 | TSHR (0.72) | TSHRALDH1A1CYP3A4RECQLHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 744 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466759-A | Preparation method of 2-amino-4-bromo-5-chlorobenzoic acid | 阜新清稷升科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| EP-3692101-B1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTR S R L (IT) | 2022-01-12 | — | — | EP | claimed |
| EP-3692101-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | Alfa Instruments S.r.l. (IT) | 2020-08-12 | — | — | EP | claimed |
| WO-2019068935-A1 | BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES | ALFA INSTRUMENTS S.R.L. (IT) | 2019-04-11 | — | — | WO | claimed |
| EP-2940009-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VentiRx Pharmaceuticals, Inc. (US) | 2015-11-04 | — | — | EP | claimed |
| EP-2358683-B1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VENTIRX PHARMACEUTICALS INC (US) | 2015-04-01 | — | — | EP | claimed |
| US-8314090-B2 | Methods of synthesis of benzazepine derivatives | VENTIRX PHARMACEUTICALS, INC. (US) | 2012-11-20 | — | — | US | claimed |
| EP-2358683-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | Ventirx Pharmaceuticals, Inc. (US) | 2011-08-24 | — | — | EP | claimed |
| US-20100216989-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VENTIRX PHARMACEUTICALS, INC. (US) | 2010-08-26 | — | — | US | claimed |
| WO-2010054215-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | VENTIRX PHARMACEUTICALS, INC. (US) | 2010-05-14 | — | — | WO | claimed |
| CN-1047377-C | Preparation method of 2-fluor-4-bromotoluene, 2-fluor-4-bromo benzyl bromide and its 2-fluor-4-bromo benzyl bromide | FUXIN SPECIAL CHEMICALS CO LTD (CN) | 1999-12-15 | — | — | CN | claimed |
| CN-1157812-A | Preparation method of 2-fluor-4-bromotoluene, 2-fluor-4-bromo benzyl bromide and its 2-fluor-4-bromo benzyl bromide | FUXIN SPECIAL CHEMICALS CO LTD (CN) | 1997-08-27 | — | — | CN | claimed |
| US-12570610-B2 | Macromolecule-supported aminobenzazepine compounds | BOLT BIOTHERAPEUTICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260049080-A1 | WILD TYPE KIT INHIBITORS | BLUEPRINT MEDICINES CORP (US) | 2026-02-19 | — | — | US | disclosed |
| US-12448379-B2 | Wild type kit inhibitors | BLUEPRINT MEDICINES CORPORATION (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250304573-A1 | LYSERGIC ACID DERIVATIVES AND METHODS | UNIV FLORIDA STATE RES FOUND INC (US) | 2025-10-02 | — | — | US | disclosed |
| US-4126626-A | DYES, POLYESTERS | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | disclosed |
| US-4020107-A | ACIDIC PHOSPHORUS COMPOUND DEHALOGENATION INHIBITOR | E. I. DU PONT DE NEMOURS AND CO. (US) | 1977-04-26 | — | — | US | disclosed |
| US-3996052-A | Phototropic compounds as acid catalyst in photopolymerizing process | AMERICAN CAN COMPANY (US) | 1976-12-07 | — | — | US | disclosed |
| US-3949143-A | Epoxy resin coatings cured with phototropic aromatic nitro compounds | AMERICAN CAN COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216989-A1 | METHODS OF SYNTHESIS OF BENZAZEPINE DERIVATIVES | MAOB, GABBR1, HNMT | TSHR 3576/4885ALDH1A1 536/4885CYP3A4 17/4885 |
| US-20260049080-A1 | WILD TYPE KIT INHIBITORS | KIT, CSNK1A1, CSNK1A1L | TSHR 3143/4885ALDH1A1 741/4885CYP3A4 2266/4885 |
| US-12448379-B2 | Wild type kit inhibitors | KIT, TNK1, TNNI3K | TSHR 4256/4885ALDH1A1 1830/4885CYP3A4 4552/4885 |
| US-20250304573-A1 | LYSERGIC ACID DERIVATIVES AND METHODS | AADAT, HTR3A, HNMT | TSHR 1456/4885ALDH1A1 2036/4885CYP3A4 1815/4885 |
| US-12570610-B2 | Macromolecule-supported aminobenzazepine compounds | BCL6, CLTB, MET | TSHR 1278/4885ALDH1A1 2418/4885CYP3A4 1879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.